VCP and neoplasm: We have shown therapeutic delivery of miR-198 using LGA-PEI as a delivery system resulted in repression of VCP-associated autophagy and sensitized PDAC to gemcitabine treatment, reducing tumor burden and metastatic spread in PDAC mouse models.